1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chin, Y.K.Y.
Ma, L.
King, G.F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Biochem. Pharmacol.
1873-2968
158
60
72
10.1016/j.bcp.2018.08.038
30149017
Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target.
2018
10.2210/pdb5wlx/pdb
pdb_00005wlx
4163.811
Kappa-theraphotoxin-Aa1a
1
syn
polymer
no
yes
GDCHKFLGWCRGEKDPCCEHLTCHVKHGWCVWDGTI(NH2)
GDCHKFLGWCRGEKDPCCEHLTCHVKHGWCVWDGTIX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
citation
citation_author
database_2
pdbx_database_status
pdbx_nmr_software
repository
Initial release
Data collection
Database references
Data collection
Database references
Other
1
0
2018-08-01
1
1
2019-02-27
1
2
2023-06-14
_citation.journal_abbrev
_citation.journal_id_CSD
_citation.journal_id_ISSN
_citation.journal_volume
_citation.page_first
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.pdbx_database_id_PubMed
_citation.title
_citation.year
_citation_author.name
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
Solution structure of kappa-theraphotoxin-Aa1a
N
RCSB
Y
RCSB
2017-07-28
REL
REL
REL
REL
446523
Avicularia
sample
1
37
Best stereochemical properties as judged by Molprobity
200
20
anisotropic
1
2D 1H-15N HSQC
anisotropic
1
2D 1H-13C HSQC
anisotropic
1
2D 1H-1H TOCSY
anisotropic
1
2D 1H-1H NOESY
1
mM
natural abundance
20
mM
natural abundance
20
mM
p31
7.4
0.05
pH
1
atm
298
K
torsion angle dynamics
1
lowest energy
1 mM Kappa-theraphotoxin-Aa1a, 20 mM sodium phosphate, 95% H2O/5% D2O
p31
95% H2O/5% D2O
solution
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
CCPN
chemical shift assignment
Analysis
CCPN
peak picking
Analysis
Bruker Biospin
collection
TopSpin
Bruker Biospin
processing
TopSpin
Guntert, Mumenthaler and Wuthrich
chemical shift assignment
CYANA
600
Bruker
B
GLY
1
n
1
GLY
1
A
ASP
2
n
2
ASP
2
A
CYS
3
n
3
CYS
3
A
HIS
4
n
4
HIS
4
A
LYS
5
n
5
LYS
5
A
PHE
6
n
6
PHE
6
A
LEU
7
n
7
LEU
7
A
GLY
8
n
8
GLY
8
A
TRP
9
n
9
TRP
9
A
CYS
10
n
10
CYS
10
A
ARG
11
n
11
ARG
11
A
GLY
12
n
12
GLY
12
A
GLU
13
n
13
GLU
13
A
LYS
14
n
14
LYS
14
A
ASP
15
n
15
ASP
15
A
PRO
16
n
16
PRO
16
A
CYS
17
n
17
CYS
17
A
CYS
18
n
18
CYS
18
A
GLU
19
n
19
GLU
19
A
HIS
20
n
20
HIS
20
A
LEU
21
n
21
LEU
21
A
THR
22
n
22
THR
22
A
CYS
23
n
23
CYS
23
A
HIS
24
n
24
HIS
24
A
VAL
25
n
25
VAL
25
A
LYS
26
n
26
LYS
26
A
HIS
27
n
27
HIS
27
A
GLY
28
n
28
GLY
28
A
TRP
29
n
29
TRP
29
A
CYS
30
n
30
CYS
30
A
VAL
31
n
31
VAL
31
A
TRP
32
n
32
TRP
32
A
ASP
33
n
33
ASP
33
A
GLY
34
n
34
GLY
34
A
THR
35
n
35
THR
35
A
ILE
36
n
36
ILE
36
A
NH2
37
n
37
NH2
37
A
author_defined_assembly
1
monomeric
none
100
0
3150
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
THR
22
A
N
THR
22
A
O
VAL
31
A
O
VAL
31
1
A
CYS
18
-69.91
-175.28
1
A
CYS
23
-53.15
104.72
1
A
TRP
29
-171.12
141.48
2
A
CYS
18
-69.80
-175.17
2
A
CYS
23
-52.99
104.65
2
A
TRP
29
-171.60
141.45
3
A
PRO
16
-69.77
-171.62
3
A
CYS
18
-69.82
-174.97
3
A
CYS
23
-51.92
104.68
3
A
TRP
29
-170.63
142.17
4
A
PRO
16
-69.72
-173.77
4
A
CYS
18
-69.95
-174.69
4
A
CYS
23
-51.80
104.69
4
A
TRP
29
-171.60
141.86
5
A
PRO
16
-69.76
-174.46
5
A
CYS
18
-69.98
-174.62
5
A
CYS
23
-52.17
104.73
5
A
TRP
29
-170.86
141.52
6
A
PRO
16
-69.72
-174.07
6
A
CYS
18
-69.97
-174.68
6
A
CYS
23
-51.96
104.71
6
A
TRP
29
-171.19
141.55
7
A
PRO
16
-69.71
-171.13
7
A
CYS
18
-69.88
-174.63
7
A
CYS
23
-51.94
104.78
7
A
TRP
29
-171.72
141.83
8
A
LYS
14
-99.05
56.35
8
A
CYS
18
-69.89
-175.37
8
A
CYS
23
-53.85
104.61
8
A
TRP
29
-170.58
141.52
9
A
PRO
16
-69.78
-173.68
9
A
CYS
18
-69.95
-174.74
9
A
CYS
23
-51.81
104.66
9
A
TRP
29
-171.72
141.57
10
A
PRO
16
-69.68
-174.25
10
A
CYS
23
-51.83
104.73
10
A
TRP
29
-170.91
141.07
11
A
PRO
16
-69.82
-173.23
11
A
CYS
18
-69.92
-174.86
11
A
CYS
23
-51.89
104.69
11
A
TRP
29
-171.14
142.02
12
A
LYS
14
-99.17
48.36
12
A
PRO
16
-69.68
-176.88
12
A
CYS
18
-69.93
-175.40
12
A
CYS
23
-54.23
104.78
12
A
TRP
29
-171.65
141.62
12
A
ASP
33
-170.72
129.51
13
A
PRO
16
-69.72
-174.53
13
A
CYS
18
-69.95
-174.73
13
A
CYS
23
-51.86
104.71
13
A
TRP
29
-171.77
142.01
14
A
PRO
16
-69.78
-173.06
14
A
CYS
18
-69.89
-169.48
14
A
CYS
23
-51.99
104.76
14
A
TRP
29
-171.71
142.48
15
A
LYS
14
-102.78
63.15
15
A
CYS
18
-69.92
-175.26
15
A
CYS
23
-53.07
104.75
15
A
TRP
29
-171.83
141.65
16
A
LYS
14
-101.82
55.14
16
A
CYS
18
-69.83
-174.44
16
A
CYS
23
-54.82
104.75
16
A
TRP
29
-171.17
142.09
17
A
PRO
16
-69.73
-174.84
17
A
CYS
18
-69.92
-174.78
17
A
CYS
23
-51.93
104.73
17
A
TRP
29
-171.88
141.86
18
A
LYS
14
-103.04
56.10
18
A
CYS
18
-69.87
-174.34
18
A
CYS
23
-53.84
104.60
18
A
TRP
29
-171.69
142.29
19
A
PRO
16
-69.85
-171.27
19
A
CYS
23
-54.17
104.74
19
A
TRP
29
-170.89
141.52
19
A
ASP
33
-128.24
-57.07
20
A
LYS
14
-108.13
67.44
20
A
CYS
18
-69.90
-174.37
20
A
CYS
23
-51.77
104.70
20
A
TRP
29
-171.81
141.36
N
Solution structure of kappa-theraphotoxin-Aa1a
1
N
N
disulf
2.000
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
18
A
SG
CYS
18
1_555
disulf
2.000
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
1.999
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
30
A
SG
CYS
30
1_555
covale
1.329
both
A
ILE
36
A
C
ILE
36
1_555
A
NH2
37
A
N
NH2
37
1_555
TOXIN
Spider toxins; Inhibitor cystine knot; Theraphotoxin, TOXIN
5WLX
PDB
1
1
5WLX
1
37
5WLX
1
37
5WLX
A
1
1
37
2
anti-parallel
A
LEU
21
A
LEU
21
A
THR
22
A
THR
22
A
VAL
31
A
VAL
31
A
TRP
32
A
TRP
32